Total amount raised
$17 Millions
Latest funding date
11/01/2019
Location
Title
Deep 6 AI has successfully raised significant funding to advance its AI-powered software for clinical trials. The platform leverages advanced AI and Natural Language Processing (NLP) to optimize trial design, site selection, patient recruitment, and real-time visibility into trial progress.
Keep reading to explore the intricacies of Deep 6 AI's fundraising journey and the investors backing this innovative platform.
What Is Deep 6 AI?
Deep 6 AI, founded in 2014, is headquartered in Pasadena, California. The company specializes in AI-powered software designed to accelerate and de-risk clinical trials by mining patient records in real time.
Although the names of the founders are not disclosed, Deep 6 AI has established itself as a leader in precision research software. Their technology optimizes trial design, site selection, patient recruitment, and real-time monitoring.
For more information about their innovative solutions, visit their official website.
How Much Funding Has Deep 6 AI Raised?
- Series A
- Amount Raised: $17 million
- Date: November 2019
- Lead Investors: Point72 Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand capacity to meet growing demand for AI-driven clinical trial tools.
Total Amount Raised: $17 million. Current Valuation: Not publicly disclosed.
Key Investors
- Point72 Ventures
- Details: Point72 Ventures is a global venture capital firm led by domain experts. It is an independent arm of Point72, a global asset management firm led by Steven A. Cohen.
- Investment Focus Areas: Fintech, AI/ML, Enterprise technologies
- Notable Investments: Not publicly disclosed
- GSR Ventures
- Details: GSR Ventures is a venture capital firm that invests primarily in early-stage technology companies. They have a strong presence in both the U.S. and China.
- Investment Focus Areas: Healthcare, AI, Consumer Internet
- Notable Investments: Didi Chuxing, Qunar, Ele.me
- Strategic Partners
- Details: The specific strategic partners involved in Deep 6 AI's funding round have not been publicly disclosed. These partners typically include industry leaders and experts.
- Investment Focus Areas: Not publicly disclosed
- Notable Investments: Not publicly disclosed
What's Next for Deep 6 AI?
Deep 6 AI stands at the cusp of significant growth, driven by the increasing demand for efficient clinical trial solutions. The company aims to expand its network of healthcare providers and trial sponsors, enhancing its suite of AI-native software products. This expansion is crucial as the healthcare industry increasingly adopts AI and data-driven approaches to accelerate clinical trials.
Future fundraising opportunities appear promising, given the successful Series A round and the high demand for their software. However, challenges such as ensuring scalability and maintaining a technological edge in a competitive market remain. Overcoming these hurdles will be essential for Deep 6 AI to sustain its growth trajectory.
Use Clay to Get Funding Data
Sales professionals, take advantage of Clay's platform to access comprehensive fundraising data on companies like Deep 6 AI and gather other critical business insights.
Sign up for free on Clay and elevate your sales strategy today.
